β-Lactam Compound Structure for Gram-Negative Resistance Control

The patent applies parameter changes by systematically modifying the chemical structure of aztreonam derivatives. Specifically, different substituent groups (R1-R6) are introduced at various positions of the beta-lactam core structure, and different side chains (Y groups including alkenyl, alkynyl, and carboxyl) are attached to the sulfur-containing side chain position. These structural parameter modifications aim to optimize both the stability against beta-lactamases and the antibacterial activity while reducing drug resistance development.

The patent applies local quality by making specific localized modifications to the aztreonam molecule. The core beta-lactam structure is preserved to maintain broad spectrum activity, while specific local regions are modified: the sulfur-containing side chain is replaced with alkenyl, alkynyl, or carboxyl groups, and specific substituent patterns (R1-R6) are introduced at defined positions. These localized changes enhance activity against Gram-negative bacteria without sacrificing the broad spectrum properties.

The patent applies composite materials concept by creating hybrid molecular structures that combine the stable beta-lactam core with diverse side chain compositions. The compounds integrate multiple functional groups (alkenyl, alkynyl, carboxyl) with the core structure in various configurations. This composite approach generates molecules with optimized properties that achieve enhanced Gram-negative bacterial activity while the structural diversity helps prevent resistance development through multiple mechanisms.